389 related articles for article (PubMed ID: 12186906)
1. Potent and specific inhibition of human immunodeficiency virus type 1 replication by RNA interference.
Coburn GA; Cullen BR
J Virol; 2002 Sep; 76(18):9225-31. PubMed ID: 12186906
[TBL] [Abstract][Full Text] [Related]
2. Down-modulation of TCR/CD3 surface complexes after HIV-1 infection is associated with differential expression of the viral regulatory genes.
Willard-Gallo KE; Furtado M; Burny A; Wolinsky SM
Eur J Immunol; 2001 Apr; 31(4):969-79. PubMed ID: 11298321
[TBL] [Abstract][Full Text] [Related]
3. Antiviral effects of human immunodeficiency virus type 1-specific small interfering RNAs against targets conserved in select neurotropic viral strains.
Dave RS; Pomerantz RJ
J Virol; 2004 Dec; 78(24):13687-96. PubMed ID: 15564478
[TBL] [Abstract][Full Text] [Related]
4. Protection of primary human T cells from HIV infection by Trev: a transdominant fusion gene.
Chinen J; Aguilar-Cordova E; Ng-Tang D; Lewis DE; Belmont JW
Hum Gene Ther; 1997 May; 8(7):861-8. PubMed ID: 9143912
[TBL] [Abstract][Full Text] [Related]
5. Expression kinetics and subcellular localization of HIV-1 regulatory proteins Nef, Tat and Rev in acutely and chronically infected lymphoid cell lines.
Ranki A; Lagerstedt A; Ovod V; Aavik E; Krohn KJ
Arch Virol; 1994; 139(3-4):365-78. PubMed ID: 7832642
[TBL] [Abstract][Full Text] [Related]
6. Choosing CCR5 or Rev siRNA in HIV-1.
Arteaga HJ; Hinkula J; van Dijk-Härd I; Dilber MS; Wahren B; Christensson B; Mohamed AJ; Smith CI
Nat Biotechnol; 2003 Mar; 21(3):230-1. PubMed ID: 12610564
[No Abstract] [Full Text] [Related]
7. Inhibition of human immunodeficiency virus type 1 replication is enhanced by a combination of transdominant Tat and Rev proteins.
Ulich C; Harrich D; Estes P; Gaynor RB
J Virol; 1996 Jul; 70(7):4871-6. PubMed ID: 8676525
[TBL] [Abstract][Full Text] [Related]
8. Distinct RNA sequences in the gag region of human immunodeficiency virus type 1 decrease RNA stability and inhibit expression in the absence of Rev protein.
Schwartz S; Felber BK; Pavlakis GN
J Virol; 1992 Jan; 66(1):150-9. PubMed ID: 1727477
[TBL] [Abstract][Full Text] [Related]
9. HIV gene regulatory proteins tat and rev and their interactions with synthetic RNA.
Asseline U; Grasby J; Hamy F; Iwai S; Mann DA; Pritchard C; Karn J; Gait MJ
Nucleic Acids Symp Ser; 1993; (29):113-4. PubMed ID: 7504239
[TBL] [Abstract][Full Text] [Related]
10. Rev of human immunodeficiency virus and Rex of the human T-cell leukemia virus type I can counteract an mRNA downregulatory element of the transferrin receptor mRNA.
Zolotukhin AS; Harford JB; Felber BK
Nucleic Acids Res; 1994 Nov; 22(22):4725-32. PubMed ID: 7984424
[TBL] [Abstract][Full Text] [Related]
11. The development and testing of retroviral vectors expressing trans-dominant mutants of HIV-1 proteins to confer anti-HIV-1 resistance.
Liem SE; Ramezani A; Li X; Joshi S
Hum Gene Ther; 1993 Oct; 4(5):625-34. PubMed ID: 8280800
[TBL] [Abstract][Full Text] [Related]
12. Cellular latency in human immunodeficiency virus-infected individuals with high CD4 levels can be detected by the presence of promoter-proximal transcripts.
Adams M; Sharmeen L; Kimpton J; Romeo JM; Garcia JV; Peterlin BM; Groudine M; Emerman M
Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3862-6. PubMed ID: 8171003
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of HIV-1 gene expression by novel macrophage-tropic DNA enzymes targeted to cleave HIV-1 TAT/Rev RNA.
Unwalla H; Banerjea AC
Biochem J; 2001 Jul; 357(Pt 1):147-55. PubMed ID: 11415445
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of human immunodeficiency virus-1 (HIV-1) replication after transduction of granulocyte colony-stimulating factor-mobilized CD34+ cells from HIV-1-infected donors using retroviral vectors containing anti-HIV-1 genes.
Bauer G; Valdez P; Kearns K; Bahner I; Wen SF; Zaia JA; Kohn DB
Blood; 1997 Apr; 89(7):2259-67. PubMed ID: 9116267
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of simian/human immunodeficiency virus replication in CD4+ T cells derived from lentiviral-transduced CD34+ hematopoietic cells.
Braun SE; Wong FE; Connole M; Qiu G; Lee L; Gillis J; Lu X; Humeau L; Slepushkin V; Binder GK; Dropulic B; Johnson RP
Mol Ther; 2005 Dec; 12(6):1157-67. PubMed ID: 16168713
[TBL] [Abstract][Full Text] [Related]
16. Mathematical model of the Tat-Rev regulation of HIV-1 replication in an activated cell predicts the existence of oscillatory dynamics in the synthesis of viral components.
Likhoshvai VA; Khlebodarova TM; Bazhan SI; Gainova IA; Chereshnev VA; Bocharov GA
BMC Genomics; 2014; 15 Suppl 12(Suppl 12):S1. PubMed ID: 25564443
[TBL] [Abstract][Full Text] [Related]
17. Modulating HIV-1 replication by RNA interference directed against human transcription elongation factor SPT5.
Ping YH; Chu CY; Cao H; Jacque JM; Stevenson M; Rana TM
Retrovirology; 2004 Dec; 1():46. PubMed ID: 15620346
[TBL] [Abstract][Full Text] [Related]
18. Novel mono- and di-DNA-enzymes targeted to cleave TAT or TAT-REV RNA inhibit HIV-1 gene expression.
Unwalla H; Banerjea AC
Antiviral Res; 2001 Aug; 51(2):127-39. PubMed ID: 11431037
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of HIV-1 replication by targeting the Rev protein.
Nakaya T; Iwai S; Fujinaga K; Otsuka E; Ikuta K
Leukemia; 1997 Apr; 11 Suppl 3():134-7. PubMed ID: 9209321
[TBL] [Abstract][Full Text] [Related]
20. Molecular biology of HIV-1: positive and negative regulatory elements important for virus expression.
Felber BK; Pavlakis GN
AIDS; 1993; 7 Suppl 1():S51-62. PubMed ID: 8363803
[No Abstract] [Full Text] [Related]
[Next] [New Search]
